MOnaliZumab in Combination With durvAlumab (MEDI4736) Plus Platinum-based chemotheRapy for First-line Treatment of Extensive Stage Small Cell Lung Cancer
Conditions: Small Cell Lung Cancer; SCLC; Extensive Stage Small Cell Lung Cancer Interventions: Drug: Durvalumab; Drug: Monalizumab; Drug: Carboplatin or Cisplatin; Drug: Etoposide Sponsors: Hirva Mamdani; AstraZeneca; Barbara Ann Karmanos Cancer Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: AstraZeneca | Cancer | Cancer & Oncology | Chemotherapy | Lung Cancer | Research | Small Cell Lung Cancer